Assessment of platelet indices in patients with neurodegenerative diseases: mean platelet volume was increased in patients with Parkinson's disease
- PMID: 24382959
- PMCID: PMC3870626
- DOI: 10.1155/2013/986254
Assessment of platelet indices in patients with neurodegenerative diseases: mean platelet volume was increased in patients with Parkinson's disease
Abstract
Platelets induce chronic inflammation which is a key step in atherosclerosis and may be involved in the progression of neurodegenerative diseases (NDD). We aimed to measure the mean platelet volume (MPV) and platelet count (PLC) in NDD patients. The present study was designed to investigate the platelet function by measuring MPV and PLC in NDD. A total of 182 outpatients with Alzheimer's (AD) or Parkinson's diseases (PD) were included. The control group consisted of 104 healthy subjects. Platelet count was similar between groups. MPV values of PD patients were higher than those of AD patients and controls (P < 0.001). MPV correlated negatively with Heohn and Yahr scale (HYS) score (P < 0.001). Increased MPV in patients with PD may point to a platelet dysfunction. High-grade inflammation presents with low levels of MPV as seen in PD patients with high HYS scores.
Figures
Similar articles
-
Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer's disease.J Psychiatr Res. 2013 May;47(5):644-9. doi: 10.1016/j.jpsychires.2013.01.014. Epub 2013 Feb 6. J Psychiatr Res. 2013. PMID: 23395109
-
The increase of mean platelet volume in patients with Alzheimer disease.Turk J Med Sci. 2014;44(6):1060-6. doi: 10.3906/sag-1212-5. Turk J Med Sci. 2014. PMID: 25552162
-
Mean platelet volume and platelet distribution width in vascular dementia and Alzheimer's disease.Platelets. 2014;25(6):433-8. doi: 10.3109/09537104.2013.831064. Epub 2013 Oct 8. Platelets. 2014. PMID: 24175580 Clinical Trial.
-
Mean Platelet Volume, Platelet Distribution Width, and Platelet Count in Varicocele: A Systematic Review and Meta-Analysis.Cell Physiol Biochem. 2016;38(6):2239-46. doi: 10.1159/000445579. Epub 2016 May 19. Cell Physiol Biochem. 2016. PMID: 27189836 Review.
-
Mean platelet volume, platelet distribution width and platelet count in erectile dysfunction: A systematic review and meta-analysis.Andrologia. 2017 Dec;49(10). doi: 10.1111/and.12777. Epub 2017 Mar 8. Andrologia. 2017. PMID: 28271535 Review.
Cited by
-
Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer's and Parkinson's Diseases: Insights into Current Medications.Biomolecules. 2023 Nov 3;13(11):1609. doi: 10.3390/biom13111609. Biomolecules. 2023. PMID: 38002291 Free PMC article. Review.
-
Morphometric and Nanomechanical Screening of Peripheral Blood Cells with Atomic Force Microscopy for Label-Free Assessment of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.Int J Mol Sci. 2023 Sep 19;24(18):14296. doi: 10.3390/ijms241814296. Int J Mol Sci. 2023. PMID: 37762599 Free PMC article. Review.
-
Parkinson's disease relevant pathological features are manifested in male Pink1/Parkin deficient rats.Brain Behav Immun Health. 2023 Jun 19;31:100656. doi: 10.1016/j.bbih.2023.100656. eCollection 2023 Aug. Brain Behav Immun Health. 2023. PMID: 37484197 Free PMC article.
-
The development and benefits of metformin in various diseases.Front Med. 2023 Jun;17(3):388-431. doi: 10.1007/s11684-023-0998-6. Epub 2023 Jul 4. Front Med. 2023. PMID: 37402952 Review.
-
A Multi-Trait Association Analysis of Brain Disorders and Platelet Traits Identifies Novel Susceptibility Loci for Major Depression, Alzheimer's and Parkinson's Disease.Cells. 2023 Jan 6;12(2):245. doi: 10.3390/cells12020245. Cells. 2023. PMID: 36672180 Free PMC article.
References
-
- Borroni B, Akkawi N, Martini G, et al. Microvascular damage and platelet abnormalities in early Alzheimer’s disease. Journal of the Neurological Sciences. 2002;203-204:189–193. - PubMed
-
- Qiu C, Hu G, Kivipelto M, et al. Association of blood pressure and hypertension with the risk of parkinson disease: the National FINRISK study. Hypertension. 2011;57(6):1094–1100. - PubMed
-
- Pluta R, Ulamek M, Jablonski M. Consideration of the ischaemic basis and treatment of Alzheimer's disease. Folia Neuropathologica. 2010;48(1):11–26. - PubMed
-
- Pluta R, Ułamek M, Jabłoński M. Alzheimer's mechanisms in ischemic brain degeneration. The Anatomical Record. 2009;292(12):1863–1881. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
